A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease

Publisher： Karger

E-ISSN： 1663-2699|3|3|443-451

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.3, Iss.3, 2012-12, pp. : 443-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 235, Iss. 4, 2016-04 ,pp. : 225-232

Karger

Access to resources Recommend Favorite

Triple Therapy for Anti-Vascular Endothelial Growth Factor Nonresponders in Neovascular Age-Related Macular Degeneration: Impact of Different Photodynamic Therapy Parameters

By  

Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. : 131-137

Karger

Access to resources Recommend Favorite

Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 18-26

Karger

Access to resources Recommend Favorite

Pharmacogenetic Effect of Complement Factor H Gene Polymorphism in Response to the Initial Intravitreal Injection of Bevacizumab for Wet Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 54, Iss. 4, 2015-0 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-03 ,pp. : 141-147

Karger

Access to resources Recommend Favorite